Meng‐Ting Peng

410 total citations
21 papers, 280 citations indexed

About

Meng‐Ting Peng is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Meng‐Ting Peng has authored 21 papers receiving a total of 280 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 4 papers in Pulmonary and Respiratory Medicine and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Meng‐Ting Peng's work include Cancer survivorship and care (3 papers), Radiomics and Machine Learning in Medical Imaging (2 papers) and CAR-T cell therapy research (2 papers). Meng‐Ting Peng is often cited by papers focused on Cancer survivorship and care (3 papers), Radiomics and Machine Learning in Medical Imaging (2 papers) and CAR-T cell therapy research (2 papers). Meng‐Ting Peng collaborates with scholars based in Taiwan, China and United States. Meng‐Ting Peng's co-authors include Chun‐Bing Chen, Wen‐Hung Chung, Shun‐Fa Yang, Chau Yee Ng, Chun‐Wei Lu, Chen‐Yang Huang, Chih‐Hsun Yang, Shih‐Chi Su, Rosaline Chung‐Yee Hui and Jennifer Wu and has published in prestigious journals such as Journal of Clinical Oncology, Scientific Reports and American Journal Of Pathology.

In The Last Decade

Meng‐Ting Peng

21 papers receiving 279 citations

Peers

Meng‐Ting Peng
Meng‐Ting Peng
Citations per year, relative to Meng‐Ting Peng Meng‐Ting Peng (= 1×) peers İbrahim Halil Türkbeyler

Countries citing papers authored by Meng‐Ting Peng

Since Specialization
Citations

This map shows the geographic impact of Meng‐Ting Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meng‐Ting Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meng‐Ting Peng more than expected).

Fields of papers citing papers by Meng‐Ting Peng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meng‐Ting Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meng‐Ting Peng. The network helps show where Meng‐Ting Peng may publish in the future.

Co-authorship network of co-authors of Meng‐Ting Peng

This figure shows the co-authorship network connecting the top 25 collaborators of Meng‐Ting Peng. A scholar is included among the top collaborators of Meng‐Ting Peng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meng‐Ting Peng. Meng‐Ting Peng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Peng, Meng‐Ting, et al.. (2024). The falls health literacy scale: translation, cultural adaptation, and validation of the Chinese version. BMC Public Health. 24(1). 2329–2329. 1 indexed citations
2.
Shen, Wen‐Chi, Shin‐Cheh Chen, Cheng‐Hsu Wang, et al.. (2024). Astragalus polysaccharides improve adjuvant chemotherapy-induced fatigue for patients with early breast cancer. Scientific Reports. 14(1). 25690–25690. 9 indexed citations
3.
Peng, Meng‐Ting, et al.. (2024). Climates and associated factors for evidence-based practice implementation among nurses: a cross-sectional study. BMC Nursing. 23(1). 62–62. 3 indexed citations
6.
Shen, Wen‐Chi, Shin‐Cheh Chen, Cheng‐Hsu Wang, et al.. (2023). Effect of astragalus polysaccharides (PG2) treatment of adjuvant chemotherapy-induced fatigue in premenopausal patients with breast cancer.. Journal of Clinical Oncology. 41(16_suppl). 537–537. 2 indexed citations
7.
Bomalaski, John S., Ko‐Ting Chen, Chi‐Ting Liau, et al.. (2022). Phase IB trial of pegylated arginine deiminase (ADI-PEG 20) plus radiotherapy and temozolomide in patients with newly diagnosed glioblastoma.. Journal of Clinical Oncology. 40(16_suppl). 2057–2057. 8 indexed citations
8.
Cheng, Wei-Jen, Meng‐Ting Peng, Yu‐Tung Huang, et al.. (2021). Chronic Obstructive Pulmonary Disease Increases the Risk of Mortality among Patients with Colorectal Cancer: A Nationwide Population-Based Retrospective Cohort Study. International Journal of Environmental Research and Public Health. 18(16). 8742–8742. 5 indexed citations
9.
Tsai, Hsin‐I, Ming‐Chin Yu, Chun‐Nan Yeh, et al.. (2021). Purely laparoscopic feeding jejunostomy: a procedure which deserves more attention. BMC Surgery. 21(1). 37–37. 4 indexed citations
10.
Wu, Chiao‐En, Meng‐Ting Peng, Pei‐Wei Huang, et al.. (2020). The association between immune-related adverse events and survival outcomes in Asian patients with advanced melanoma receiving anti-PD-1 antibodies. BMC Cancer. 20(1). 1018–1018. 30 indexed citations
11.
Lin, Chiao‐Yun, Angel Chao, Ren‐Chin Wu, et al.. (2020). Synergistic effects of pazopanib and hyperthermia against uterine leiomyosarcoma growth mediated by downregulation of histone acetyltransferase 1. Journal of Molecular Medicine. 98(8). 1175–1188. 8 indexed citations
12.
Wu, Chiao‐En, Meng‐Ting Peng, Pei‐Wei Huang, et al.. (2020). Immune Checkpoint Inhibitors for Advanced Melanoma: Experience at a Single Institution in Taiwan. Frontiers in Oncology. 10. 905–905. 16 indexed citations
13.
Chen, Chun‐Bing, Chau Yee Ng, Chun‐Wei Lu, et al.. (2018). Severe cutaneous adverse reactions induced by targeted anticancer therapies and immunotherapies. Cancer Management and Research. Volume 10. 1259–1273. 109 indexed citations
14.
Liaw, Chuang‐Chi, et al.. (2018). Prognostic factors of metastatic testicular non-seminomatous germ cell tumors after chemotherapy. Journal of Cancer Research and Practice. 5(3). 99–104. 2 indexed citations
15.
Peng, Meng‐Ting, Shin‐Cheh Chen, Wen‐Chi Shen, Yung‐Chang Lin, & Hsien‐Kun Chang. (2016). The adherence and tolerance of adjuvant endocrine therapy in geriatric breast cancer patients. Journal of Cancer Research and Practice. 3(3). 69–72. 1 indexed citations
16.
Yeh, Jih‐Kai, Meng‐Ting Peng, Shian‐Sen Shie, et al.. (2015). Circadian CLOCK Mediates Activation of Transforming Growth Factor-β Signaling and Renal Fibrosis through Cyclooxygenase 2. American Journal Of Pathology. 185(12). 3152–3163. 46 indexed citations
17.
Chou, Wen‐Chi, Kun‐Yun Yeh, Meng‐Ting Peng, et al.. (2015). Development and Validation of a Prognostic Score to Predict Survival in Adult Patients With Solid Tumors and Bone Marrow Metastases. Medicine. 94(23). e966–e966. 7 indexed citations
18.
Chou, Wen‐Chi, Meng‐Ting Peng, Chien-Ting Liu, et al.. (2015). Development and validation of a prognostic score to predict the survival in adult patients with solid tumors and bone marrow metastases.. Journal of Clinical Oncology. 33(15_suppl). e17730–e17730. 1 indexed citations
19.
Peng, Meng‐Ting, Chien-Ting Liu, Yu‐Shin Hung, et al.. (2014). Sequential Assessments of the Eastern Cooperative Oncology Group Performance Scale Enhance Prognostic Value in Patients With Terminally Ill Cancer Receiving Palliative Care. American Journal of Hospice and Palliative Medicine®. 33(5). 471–476. 11 indexed citations
20.
Peng, Meng‐Ting, et al.. (2014). Staff radiation safety in sentinel lymph node detection for breast cancer patients. International Journal of Evidence-Based Healthcare. 12(3). 180–180. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026